NASDAQ: NAUT - Nautilus Biotechnology, Inc.

Yield per half year: -19.2%
Sector: Healthcare

Current price
2.82 $
Average price
1.58 $ -43.81%

Price based on EPS
2.84 $ +0.8375%
5/10

Price based on EPS

Price = Price * (100 - CAGR EPS * Excess Key Rate) / 100
Key Rate = Key rate
Fair price = 2.84 $
Current price = 2.82 $ (difference = +0.8375%)


Data

Discounted Cash Flow (Based EBITDA)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount Ebitda(5) * (1 + Ebitda Yield) / (WACC - Ebitda Yield)
Company Value = ∑ (Future Ebitda / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = 0.3253 $
Current price = 2.82 $ (difference = -88.46%)


Data

Discounted Cash Flow (Based FCF)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount FCF(5) * (1 + FCF Yield) / (WACC - FCF Yield) ^ 5
Company Value = ∑ (FCF / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = -73.3 $
Current price = 2.82 $ (difference = -2 699.32%)


Data

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription